New England Research & Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-2,450
| Closed | -$506K | – | 163 |
|
|
2024
Q2 | $506K | Buy |
+2,450
| New | +$506K | 0.24% | 121 |
|
|
2020
Q1 | – | Sell |
-4,500
| Closed | -$687K | – | 144 |
|
|
2019
Q4 | $687K | Sell |
4,500
-2,225
| -33% | -$340K | 0.46% | 79 |
|
|
2019
Q3 | $890K | Sell |
6,725
-250
| -4% | -$33.1K | 0.64% | 54 |
|
|
2019
Q2 | $990K | Buy |
+6,975
| New | +$990K | 0.67% | 49 |
|
|
2019
Q1 | – | Sell |
-3,300
| Closed | -$373K | – | 170 |
|
|
2018
Q4 | $373K | Sell |
3,300
-7,500
| -69% | -$848K | 0.29% | 103 |
|
|
2018
Q3 | $1.45M | Buy |
+10,800
| New | +$1.45M | 0.95% | 34 |
|